Atlas Trials

Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

Clinical trial NCT06001528 · RECRUITING

Trial details

NCT number
NCT06001528
Sponsor
Shantou Central Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Breast CancerLymph Node Metastasis
Start date
2021-01-01
Primary completion
2023-12-31
Enrollment
2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.